GlassScriptPhysician profile
Aarthi Ram
NPI 1851611578
$12,856.24
in general payments reported to CMS, 2019-2025
62 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,535 · 2020: $1,025 · 2021: $3,748 · 2022: $1,610 · 2023: $1,453 · 2024: $1,149 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,868 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,867.62 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $3,216.11 | 2019-2025 | Xywav |
| Abbvie INC. | $1,314.73 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $810.91 | 2019-2022 | |
| Ucb, INC. | $587.75 | 2019-2025 | Nayzilam, Briviact, Fintepla |
| Livanova USA, INC. | $498.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $493.81 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $412.15 | 2019-2024 | Austedo Xr, Austedo |
| Acadia Pharmaceuticals INC | $402.87 | 2019-2025 | Nuplazid |
| Csl Behring | $381.43 | 2019-2025 | Hizentra |
| Pfizer INC. | $362.19 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $349.34 | 2019-2021 | |
| Lilly USA, LLC | $258.07 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Eisai INC. | $254.78 | 2019-2025 | |
| Grifols USA, LLC | $244.46 | 2019-2025 | Gamunex-C |
| Inspire Medical Systems, INC. | $244.18 | 2023-2024 | Inspire |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aarthi Ram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.